Armstrong, Stacey B.

Bio

Stacey B. Armstrong, PhD, serves as the Associate Director and Senior Researcher at the Center for Psychedelic Drug Research and Education (CPDRE) at The Ohio State University. She earned her Ph.D. in psychology from Bowling Green State University after completing a clinical internship at the University of Michigan in Ann Arbor, MI. Her clinical fellowship at the Traumatic Stress Center in Akron, OH, centered on utilizing evidence-based treatments for posttraumatic stress disorder (PTSD) in both veterans and civilians, including cognitive processing therapy (CPT) and prolonged exposure (PE). Additionally, she completed a research fellowship at The Ohio State University, evaluating the safety and effectiveness of psilocybin, a novel investigational psychedelic drug, for treating treatment-resistant PTSD among US military veterans. Apart from her work on PTSD, Dr. Armstrong is a co-investigator in a clinical trial evaluating the safety and efficacy of psilocybin and 5-MeO-DMT for the treatment of depression in stage 4 lung cancer patients. She is also investigating the usage patterns and immediate subjective effects of psychoactive substances in both clinical and non-clinical settings, measuring attitudes and beliefs about psychedelic-assisted therapies among mental health professionals, and leading a global registry for patients with opioid use disorder who seek psychedelic therapy internationally to gather real-world evidence on the safety and efficacy of ibogaine as a treatment for addiction. Dr. Armstrong has a keen interest in the subjective effects of psychedelics and their influence on treatment outcomes, as well as how psychedelic-assisted therapies might assist populations currently excluded from clinical trials.

Education

PhD - Bowling Green State University - Psychology
MA - Bowling Green State University - Psychology
BS - University of Arizona - Family Studies and Human Development